Altogether, our work proposes that the synergetic cooperation between c-Myc and Oct4 could promote MEndoT capacity of cMSCs, diminish the negative effects of cardiac inflammation on the MSC’s reparative properties, enhance cell retention, and improve the outcome of cell therapy after MI. The gene discussed is POU5F1; the disease is myocardial infarction.